Camberlogo1 (Camberlogo1)
Sildenafil Tablet, Film Coated
Product Images NDC 31722-967
14 FDA label images from Camber Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 31722-967). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Camberlogo2 (Camberlogo2)
Sildenafilfigure7 (Sildenafilfigure7)
A bar chart showing the percentage of patients reporting improvement by treatment group for Sildenafil Citrate tablets versus placebo. The groups include placebo and Sildenafil Citrate tablets at 25 mg, 50 mg, and 100 mg doses, with the percentage improvement increasing progressively from placebo to 100 mg dose.*
Evaric100mg (Evaric100mg)
Sildenafil Tablets, USP 100 mg film-coated tablets package label by Camber Pharmaceuticals, Inc. The label shows the product name, strength, NDC number, and quantity of 30 tablets. It includes storage instructions, dosage form, and manufacturer details along with a barcode and a noted unvarnished area of 25 x 30 mm on one side.*
Evaric25mg (Evaric25mg)
Sildenafil Tablets, USP 25 mg film-coated oral tablets packaged in a container label by Camber Pharmaceuticals, Inc. The label states NDC 31722-965-30 and indicates a 30-tablet count. Storage instructions, contact information, and dosage details are also included on the label.*
Evaric50mg (Evaric50mg)
Sildenafil Tablets, USP 50 mg film-coated tablets packaging label from Camber Pharmaceuticals, Inc. The label shows a box containing 30 tablets with a barcode on the left side and dosage information including storage instructions, contact information, and directions for use. The label indicates that the product is prescription only.*
Sildenafilfigure1 (Sildenafilfigure1)
A line graph comparing systolic blood pressure (mmHg) over 24 hours post-dose between Sildenafil 100 mg and placebo. The x-axis represents time in hours, including a pre-dose baseline, while the y-axis shows changes in systolic blood pressure. Two lines depict the pressure changes for Sildenafil and placebo groups at various time points.*
Sildenafilfigure2 (Sildenafilfigure2)
A line graph comparing the change in SBP (mmHg) over time (hours) for two treatments: placebo and Citalopram 15 mg. The graph plots SBP changes from 0 to 8 hours postdose, showing separate trend lines for each treatment.*
Sildenafilfigure3 (Sildenafilfigure3)
A line graph depicting percent change in blood pressure over time (hours) after administration of Sildenafil 50 mg compared with placebo. The x-axis represents time postdose in hours, and the y-axis shows change in blood pressure as a percentage. Two lines are plotted: one for placebo and one for Sildenafil 50 mg, tracking blood pressure changes across an 8-hour period.*
Sildenafilfigure4 (Sildenafilfigure4)
A line graph comparing the effects of Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with placebo over time after dosing (in hours). The y-axis represents a numerical value in mmHg, showing changes from baseline, with data points plotted up to 8 hours post-dose.*
Sildenafilfigure5 (Sildenafilfigure5)
A line graph depicting plasma concentration (ng/mL) over time (hours) for a commercial tablet treatment. The graph shows a rapid rise in plasma concentration soon after dosing, peaking around 1 hour, then gradually declining over a 24-hour period.*
Sildenafilfigure6a (Sildenafilfigure6a)
A bar chart depicting the percentage of patients at endpoint across various baseline scores from 0 to 5. Multiple bar groups represent different categorical data series, with the percentage of patients on the vertical axis and baseline scores on the horizontal axis. The chart uses a legend with categories labeled 0 through 5.*
Sildenafilfigure6b (Sildenafilfigure6b)
A bar graph showing the percentage of patients at endpoint categorized by baseline score. The x-axis represents baseline scores ranging from 0 to 5, and the y-axis shows the percentage of patients. Multiple bar groups correspond to different endpoint scores (0 through 5), as indicated by a legend on the right.*
Sildenafilstructure (Sildenafilstructure)
Chemical structure diagram of the active ingredient Sildenafil, showing its molecular composition and arrangement of chemical groups as depicted in the image.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
